+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 4
Age: 29Years - 80Years
All Genders
ID01779284

24-Hour Efficacy of TravoprostTimolol Benzalkonium Chloride BAK Free Compared With LatanoprostTimolol Fixed Combination Therapy in Subjects With Open-Angle Glaucoma Insufficiently Controlled With Latanoprost Monotherapy

Led by Aristotle University Of Thessaloniki · Updated on 2014-05-12

42

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

The primary objective of this crossover trial is to compare the 3-month, mean 24-hour intraocular pressure (IOP) control and safety obtained with two popular fixed combinations in glaucoma patients insufficiently controlled with latanoprost monotherapy. This study will compare the 24-hour efficacy of travoprost/timolol fixed combination without benzalkonium chloride given once in the evening, versus the latanoprost/timolol fixed combination given in the evening. It is assumed that travoprost/timolol fixed combination will provide better quality of 24-hour pressure control.

CONDITIONS

Brief Title

Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here